UBS Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
|
|||||
|
2025
Q1 | $9.11M | Buy |
|
|||||
|
2024
Q4 | $485K | Sell |
|
|||||
|
2024
Q3 | $1.23M | Buy |
|
|||||
|
2024
Q2 | $867K | Sell |
|
|||||
|
2024
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q4 | $401K | Buy |
|
|||||
|
2023
Q3 | $316K | Sell |
|
|||||
|
2023
Q2 | $716K | Buy |
|
|||||
|
2023
Q1 | $76.2K | Sell |
|
|||||
|
2022
Q4 | $1.61M | Buy |
|
|||||
|
2022
Q3 | $273K | Sell |
|
|||||
|
2022
Q2 | $449K | Sell |
|
|||||
|
2022
Q1 | $1.19M | Buy |
|
|||||
|
2021
Q4 | $923K | Sell |
|
|||||
|
2021
Q3 | $758K | Buy |
|
|||||
|
2021
Q2 | $126K | Sell |
|
|||||
|
2021
Q1 | $905K | Buy |
|
|||||
|
2020
Q4 | $36K | Buy |
|
|||||
|
2020
Q3 | $7K | Sell |
|
|||||
|
2020
Q2 | $16K | Sell |
|
|||||
|
2020
Q1 | $12K | Sell |
|
|||||
|
2019
Q4 | $23K | Sell |
|
|||||
|
2019
Q3 | $1.3M | Buy |
|
|||||
|
2019
Q2 | $1.08M | Buy |
|
|||||
|
2019
Q1 | $338K | Sell |
|
|||||
|
2018
Q4 | $2.51M | Buy |
|
|||||
|
2018
Q3 | $1.44M | Buy |
|
|||||
|
2018
Q2 | $252K | Sell |
|
|||||
|
2018
Q1 | $5.09M | Buy |
|
|||||
|
2017
Q4 | $1.55M | Buy |
|
|||||
|
2017
Q3 | $98K | Sell |
|
|||||
|
2017
Q2 | $80K | Buy |
|
|||||
|
2017
Q1 | $3K | Buy |
|